Please assess the completion status of the following clinical trial:

Trial Title: Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Males aged 18-45 years~* BMI approximately ≥ 25 and \< 35~* insulin approximately ≥ 15 µU/ml or triglyceride approximately ≥ 130 mg/dl~Exclusion Criteria:~* Any DSM-IV Axis I diagnosis~* prisoners~* any serious medical disorder (i.e. metabolic diseases, type 1 or 2 diabetes mellitus, endocrine disease, coagulopathy, clinically significant anemia, acute infection)~* taking prescription medications~* non-sedentary lifestyle with \> 3 hours of exercise per week

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- olanzapine (Type: ACTIVE_COMPARATOR): olanzapine injection in healthy control
- ziprasidone (Type: ACTIVE_COMPARATOR): ziprasidone injection in healthy control
- saline (Type: PLACEBO_COMPARATOR): saline injection in healthy control

Based on this trial design, predict the completion outcome and termination type (if applicable).